[Not Available].
作者信息
Lambert Leah K, Balneaves Lynda G, Howard A Fuchsia
机构信息
École des sciences infirmières, Université de la Colombie-Britannique, T201-221 Wesbrook Mall, Vancouver, C.-B. V6T 2B5 ; British Columbia Cancer, 600 West 10th Ave, Vancouver, C.-B. V5Z 4E6.
Collège des sciences infirmières, Faculté des sciences de la santé Rady, Université du Manitoba, 89 Curry Place, Helen Glass Centre for Nursing, Winnipeg, MB R3T 2N2.
出版信息
Can Oncol Nurs J. 2021 May 1;31(2):228-234. eCollection 2021 Spring.
Abstract
摘要
相似文献
1
[Not Available].[无可用信息]。
Can Oncol Nurs J. 2021 May 1;31(2):228-234. eCollection 2021 Spring.
本文引用的文献
1
Projected estimates of cancer in Canada in 2020.2020 年加拿大癌症预估。
CMAJ. 2020 Mar 2;192(9):E199-E205. doi: 10.1503/cmaj.191292.
2
Interventions to Improve Medication Adherence: A Review.干预措施以提高用药依从性：综述。
JAMA. 2018 Dec 18;320(23):2461-2473. doi: 10.1001/jama.2018.19271.
3
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.激素受体阳性乳腺癌妇女的辅助内分泌治疗：ASCO 临床实践指南更新焦点。
J Clin Oncol. 2019 Feb 10;37(5):423-438. doi: 10.1200/JCO.18.01160. Epub 2018 Nov 19.
4
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.了解乳腺癌幸存者辅助内分泌治疗的持续情况。
BMC Cancer. 2018 Jul 11;18(1):732. doi: 10.1186/s12885-018-4644-7.
5
Women's Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions.女性对乳腺癌辅助内分泌治疗早期依从性的信念：一项基于理论的定性研究，以指导社区药剂师干预措施的制定。
Pharmacy (Basel). 2018 Jun 9;6(2):53. doi: 10.3390/pharmacy6020053.
6
Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?改善乳腺癌幸存者内分泌治疗依从性的干预措施：有哪些证据？
J Cancer Surviv. 2018 Jun;12(3):348-356. doi: 10.1007/s11764-017-0674-4. Epub 2018 Feb 2.
7
Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.患者报告的与乳腺癌辅助内分泌治疗依从性相关的因素：综合评价。
Breast Cancer Res Treat. 2018 Feb;167(3):615-633. doi: 10.1007/s10549-017-4561-5. Epub 2017 Nov 6.
8
Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review.乳腺癌女性辅助激素治疗依从性和持续性的障碍与促进因素：一项系统综述
Patient Prefer Adherence. 2017 Feb 23;11:305-322. doi: 10.2147/PPA.S126651. eCollection 2017.
9
"Winging It": How Older Breast Cancer Survivors Persist With Aromatase Inhibitor Treatment.“随机应变”：老年乳腺癌幸存者如何坚持接受芳香化酶抑制剂治疗
J Oncol Pract. 2016 Dec;12(12):e991-e1000. doi: 10.1200/JOP.2016.011767. Epub 2016 Sep 30.
10
Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis.探索医生就辅助内分泌治疗与正在接受治疗的乳腺癌患者沟通的作用：一项定性分析。
Support Care Cancer. 2017 Jan;25(1):75-83. doi: 10.1007/s00520-016-3389-6. Epub 2016 Aug 24.
Zotero 插件